S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
S&P 500   3,841.94 (+1.95%)
DOW   31,496.30 (+1.85%)
QQQ   308.68 (+1.51%)
AAPL   121.42 (+1.07%)
MSFT   231.60 (+2.15%)
FB   264.28 (+2.58%)
GOOGL   2,097.07 (+3.10%)
TSLA   597.95 (-3.78%)
AMZN   3,000.46 (+0.77%)
NVDA   498.46 (+0.74%)
BABA   233.89 (+1.47%)
CGC   31.17 (+0.52%)
GE   13.60 (+0.29%)
MU   88.93 (+5.45%)
NIO   38.11 (-2.98%)
AMD   78.52 (+0.99%)
T   29.62 (+2.42%)
F   12.27 (+2.85%)
ACB   9.60 (-2.24%)
DIS   189.99 (+1.04%)
BA   223.22 (-0.66%)
NFLX   516.39 (+1.00%)
BAC   36.93 (+1.18%)
Log in
NASDAQ:PPD

PPD Stock Forecast, Price & News

$34.76
+1.22 (+3.64 %)
(As of 03/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$33.26
Now: $34.76
$35.17
50-Day Range
$31.77
MA: $35.53
$38.04
52-Week Range
$10.61
Now: $34.76
$38.76
Volume1.55 million shs
Average Volume1.02 million shs
Market Capitalization$12.18 billion
P/E Ratio231.73
Dividend YieldN/A
BetaN/A
PPD, Inc. provides drug development services to the biopharmaceutical industry worldwide. The company operates through Clinical Development Services and Laboratory Services segments. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri- and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company was founded in 1985 and is headquartered in Wilmington, North Carolina.
PPD logo

Headlines

Sadboys part ways with captain ppd
March 4, 2021 |  reuters.com
Sadboys part ways with captain ppd - Reuters
March 4, 2021 |  reuters.com
PPD, Inc. 2020 Q4 - Results - Earnings Call Presentation
February 24, 2021 |  seekingalpha.com
PPD Inc to Host Earnings Call - Benzinga
February 24, 2021 |  benzinga.com
PPD to Present at Barclays Global Healthcare Conference
February 24, 2021 |  finance.yahoo.com
PPD Q4 Results Top Estimates - Nasdaq
February 24, 2021 |  nasdaq.com
PPD: Q4 Earnings Insights - Yahoo Finance
February 24, 2021 |  finance.yahoo.com
PPD EPS beats by $0.03, beats on revenue - Seeking Alpha
February 23, 2021 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Commercial physical research
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:PPD
CUSIPN/A
CIKN/A
Phone910-251-0081
Employees25,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.03 billion

Profitability

Net Income$47.82 million

Miscellaneous

Market Cap$12.18 billion
Next Earnings Date5/5/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.75 out of 5 stars

Medical Sector

200th out of 1,972 stocks

Commercial Physical Research Industry

6th out of 42 stocks

Analyst Opinion: 1.5Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -
$34.76
+1.22 (+3.64 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive PPD News and Ratings via Email

Sign-up to receive the latest news and ratings for PPD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











PPD (NASDAQ:PPD) Frequently Asked Questions

Is PPD a buy right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PPD in the last year. There are currently 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" PPD stock.
View analyst ratings for PPD
or view top-rated stocks.

What stocks does MarketBeat like better than PPD?

Wall Street analysts have given PPD a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but PPD wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting PPD?

PPD saw a increase in short interest in February. As of February 12th, there was short interest totaling 4,280,000 shares, an increase of 28.1% from the January 28th total of 3,340,000 shares. Based on an average daily trading volume, of 970,600 shares, the short-interest ratio is presently 4.4 days. Approximately 3.7% of the shares of the company are sold short.
View PPD's Short Interest
.

When is PPD's next earnings date?

PPD is scheduled to release its next quarterly earnings announcement on Wednesday, May 5th 2021.
View our earnings forecast for PPD
.

How were PPD's earnings last quarter?

PPD, Inc. (NASDAQ:PPD) posted its earnings results on Wednesday, February, 24th. The company reported $0.39 EPS for the quarter, topping the Zacks' consensus estimate of $0.36 by $0.03. The business had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $1.28 billion. PPD had a negative trailing twelve-month return on equity of 11.06% and a net margin of 0.21%. The business's revenue for the quarter was up 30.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.33 EPS.
View PPD's earnings history
.

How has PPD's stock price been impacted by Coronavirus?

PPD's stock was trading at $25.76 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, PPD stock has increased by 34.9% and is now trading at $34.76.
View which stocks have been most impacted by COVID-19
.

What guidance has PPD issued on next quarter's earnings?

PPD issued an update on its FY21 earnings guidance on Tuesday, February, 23rd. The company provided earnings per share (EPS) guidance of $1.37-1.45 for the period, compared to the Thomson Reuters consensus estimate of $1.39. The company issued revenue guidance of $5.145-5.304 billion, compared to the consensus revenue estimate of $5.07 billion.

What price target have analysts set for PPD?

11 Wall Street analysts have issued 12-month target prices for PPD's stock. Their forecasts range from $20.00 to $42.00. On average, they anticipate PPD's stock price to reach $36.82 in the next year. This suggests a possible upside of 5.9% from the stock's current price.
View analysts' price targets for PPD
or view top-rated stocks among Wall Street analysts.

Who are PPD's key executives?

PPD's management team includes the following people:
  • Mr. David S. Simmons, Chairman & CEO (Age 56, Pay $3.12M)
  • Mr. Christopher G. Scully, Exec. VP, CFO, Treasurer & Assistant Sec. (Age 50, Pay $920.88k)
  • Mr. William J. Sharbaugh, Chief Operating Officer (Age 58, Pay $990.82k)
  • Mr. B. Judd Hartman, Exec. VP, Gen. Counsel, Sec. & Chief Admin. Officer (Age 57, Pay $753.1k)
  • Mr. Anshul Thakral, Exec. VP & Chief Commercial Officer (Age 43, Pay $746k)
  • Mr. Glen Donovan, Chief Accounting Officer (Age 47)
  • Mr. Ronald E. Garrow, Exec. VP & Chief HR Officer (Age 57)
  • Mr. Christopher C. Fikry M.D., Exec. VP of Global Laboratory Services (Age 44)
  • Dr. David Michael Johnston, Exec. VP of Global Clinical Devel. (Age 52)
  • Mrs. Karen Kaucic, Chief Medical Officer, Exec. VP & Pres of Evidera (Age 61)

Who are some of PPD's key competitors?

What other stocks do shareholders of PPD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PPD investors own include Cisco Systems (CSCO), Alibaba Group (BABA), Johnson & Johnson (JNJ), salesforce.com (CRM), Pfizer (PFE), CVS Health (CVS), Intel (INTC), NVIDIA (NVDA), Raytheon Technologies (RTX) and Verizon Communications (VZ).

When did PPD IPO?

(PPD) raised $1.5 billion in an initial public offering (IPO) on Thursday, February 6th 2020. The company issued 60,000,000 shares at $24.00-$27.00 per share. Barclays, J.P. Morgan, Morgan Stanley, Goldman Sachs, BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird and William Blair served as the underwriters for the IPO and BofA Securities, Credit Suisse, Jefferies, UBS Investment Bank, Citigroup, Deutsche Bank Securities, Evercore ISI, HSBC, Mizuho Securities, Baird, William Blair and Drexel Hamilton were co-managers.

What is PPD's stock symbol?

PPD trades on the NASDAQ under the ticker symbol "PPD."

Who are PPD's major shareholders?

PPD's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (3.83%), Price T Rowe Associates Inc. MD (3.73%), UBS Asset Management Americas Inc. (2.16%), D1 Capital Partners L.P. (0.86%), Boston Partners (0.84%) and Boston Partners (0.84%). Company insiders that own PPD stock include Carlyle Group Management LLC, Christopher Fikry, Colin Hill, David Michael Johnston, David S Simmons, Glen Donovan, Jill Pellegrino, Karen Kaucic, Ronald E Garrow and William J Sharbaugh.
View institutional ownership trends for PPD
.

Which institutional investors are selling PPD stock?

PPD stock was sold by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., Alyeska Investment Group L.P., D1 Capital Partners L.P., Clearbridge Investments LLC, Pura Vida Investments LLC, Brookfield Asset Management Inc., Renaissance Technologies LLC, and Laurion Capital Management LP. Company insiders that have sold PPD company stock in the last year include Carlyle Group Management LLC, Colin Hill, David Michael Johnston, David S Simmons, Glen Donovan, Jill Pellegrino, Karen Kaucic, and Ronald E Garrow.
View insider buying and selling activity for PPD
or view top insider-selling stocks.

Which institutional investors are buying PPD stock?

PPD stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, BlackRock Inc., Price T Rowe Associates Inc. MD, UBS Asset Management Americas Inc., Swiss National Bank, Jennison Associates LLC, Sumitomo Mitsui Trust Holdings Inc., and Nuveen Asset Management LLC. Company insiders that have bought PPD stock in the last two years include Christopher Fikry, David S Simmons, and William J Sharbaugh.
View insider buying and selling activity for PPD
or or view top insider-buying stocks.

How do I buy shares of PPD?

Shares of PPD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is PPD's stock price today?

One share of PPD stock can currently be purchased for approximately $34.76.

How much money does PPD make?

PPD has a market capitalization of $12.18 billion and generates $4.03 billion in revenue each year. The company earns $47.82 million in net income (profit) each year or $0.98 on an earnings per share basis.

How many employees does PPD have?

PPD employs 25,000 workers across the globe.

What is PPD's official website?

The official website for PPD is www.ppdi.com.

Where are PPD's headquarters?

PPD is headquartered at 929 NORTH FRONT STREET, WILMINGTON NC, 28401.

How can I contact PPD?

PPD's mailing address is 929 NORTH FRONT STREET, WILMINGTON NC, 28401. The company can be reached via phone at 910-251-0081 or via email at [email protected]


This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.